Publications by authors named "Peter Vickerman"

Claim this Profile
A
Addressing policy barriers to scaling up needle and syringe programmes: a global call to action.
Guillaume Fontaine, Emma Day, Niklas Luhmann, Annie Madden, Keith Sabin, Peter Vickerman

Lancet Glob Health· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using modelling and public health surveillance data to evidence progress towards the WHO incidence target for hepatitis C elimination in people who inject drugs - a review of complementary approaches in the United Kingdom.
Holly D Mitchell, India Clancy, Daniela De Angelis, Conor Egan, Ross J Harris, Peter Vickerman

Int J Drug Policy· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preferences for harm reduction vending machine design among rural people who use drugs.
April M Young, Tasfia Jahangir, Susan Westneat, Chelsi Cheatom, Amanda Fallin-Bennett, Peter Vickerman

Drug Alcohol Depend Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal provision of opiate substitution therapy and needle and syringe programmes: a multi-method realist evaluation.
Peter McCulloch, April Shaw, Gail Gilchrist, Catriona Matheson, Margaret Maxwell, Peter Vickerman

Health Technol Assess· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leveraging injection networks to prevent HIV and other blood borne infections among people who inject drugs in Kenya: design and rationale.
Matthew J Akiyama, Hannah N Manley, Lindsey R Riback, Chenshu Zhang, Amirhossein Alvandi, Peter Vickerman

BMC Infect Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterising benzodiazepine use and the association with non-fatal overdose among people who inject opioids in England, Wales and Northern Ireland.
Megan Minett-Smith, Holly D Mitchell, Eleanor Clarke, Peter Vickerman, Matthew Hickman

Int J Drug Policy· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential risk for Hepatitis C and HIV among people who inject drugs in Kenya: a latent class analysis signaling needs for innovation in service delivery.
Hannah N Manley, Lindsey R Riback, Chenshu Zhang, Peter Vickerman, Jack Stone

Int J Drug Policy· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Efficiency and Safety of Hepatitis C Treatment Among People Who Inject Drugs in Vietnam.
Didier Laureillard, Nguyen Thanh Binh, Vu Hai Vinh, Tran Thi Hong, Catherine Quillet, Peter Vickerman

J Viral Hepat· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying priority populations for HIV interventions using acquisition and transmission indicators: a combined analysis of 15 mathematical models from ten African countries.
Romain Silhol, Ross D Booton, Kate M Mitchell, James Stannah, Oliver Stevens, Peter Vickerman

Lancet HIV· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk prediction models for targeted testing of HIV, hepatitis B and hepatitis C: a systematic review and meta-analysis.
Werner Leber, Hamzah Z Farooq, Jasmina Panovska-Griffiths, Harriet Larvin, Rebecca F Baggaley, Peter Vickerman

BMC Infect Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unit costs of opioid agonist therapy: a global systematic review and cost extrapolation.
Anh Truc Vo, Adriane Wynn, Marycris Hernandez, Fern Terris-Prestholt, Peter Vickerman

AIDS· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating the annual number of hepatitis C virus infections through vertical transmission at country, regional, and global levels: a data synthesis study.
Adam Trickey, Adelina Artenie, Jordan J Feld, Peter Vickerman

Lancet Gastroenterol Hepatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Factors for Hepatitis C Virus Among the General Population in Sub-Saharan Africa-An Analysis of Systematic Review Data.
Getahun Molla Kassa, Aaron G Lim, Melaku Tileku Tamiru, Tesfa Sewunet Alamneh, Peter Vickerman

J Viral Hepat· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of cuts in the US President's Emergency Plan for AIDS Relief funding for HIV pre-exposure prophylaxis in sub-Saharan Africa: a modelling study.
Jack Stone, Kennedy Kipkoech Mutai, Adelina Artenie, Romain Silhol, Marie-Claude Boily, Peter Vickerman

Lancet HIV· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact and cost-effectiveness of interventions to eliminate hepatitis C virus among people who inject drugs in Haiphong, Vietnam.
Adam Trickey, Josephine G Walker, Pham Minh Khue, Tran Thi Hong, Nguyen Thanh Binh, Peter Vickerman

Int J Drug Policy· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling the impact of changing drug markets and structural determinants on HCV and/or HIV transmission among people who inject drugs in the United States: A rural and urban comparison.
Natasha K Martin, Daniela Abramovitz, William H Eger, Joseph R Friedman, Annick Borquez, Peter Vickerman

Int J Drug Policy· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sexually transmitted infection prevalence and testing coverage among people who inject drugs: A systematic review.
Olivia Price, Paige Webb, Jason Grebely, Amy Peacock, Nicholas Medland, Peter Vickerman

Drug Alcohol Depend· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Hepatitis C Virus Case Finding and Treatment in Eastern Europe and Central Asia.
Josephine G Walker, Irina Tskhomelidze Schumacher, Adam Trickey, Peter Vickerman

Liver Int· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leveraging Injection Networks to Prevent HIV and Other Blood Borne Infections Among People Who Inject Drugs in Kenya: Design and Rationale.
Matthew J Akiyama, Hannah N Manley, Lindsey R Riback, Chenshu Zhang, Amirhossein Alvandi, Peter Vickerman

Res Sq· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of vaccination strategies to control future mpox outbreaks in England: a modelling study.
Xu-Sheng Zhang, Siwaporn Niyomsri, Sema Mandal, Hamish Mohammed, Miranda Mindlin, Peter Vickerman

Lancet Reg Health Eur· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C virus cascade of care among adults in Sindh province, Pakistan: Findings from 2019-2020 household sero-survey.
Tesfa Sewunet Alamneh, Josephine G Walker, Aaron G Lim, Ejaz Alam, Saeed Hamid, Peter Vickerman

PLOS Glob Public Health· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of scaling up harm reduction interventions on injecting risk behaviours, ART outcomes and HIV incidence among people who inject drugs in Kenya.
Josephine G Walker, Matthew J Akiyama, Adelina Artenie, Charles M Cleland, John A Lizcano, Peter Vickerman

Int J Drug Policy· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential impact and cost-effectiveness of oral HIV pre-exposure prophylaxis for men who have sex with men in Cotonou, Benin: a mathematical modelling study.
Trystan Leng, Léon Kessou, Jesse Heitner, Fernand A Guédou, Luc Béhanzin, Peter Vickerman

Lancet Glob Health· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global, regional, and national estimates of hepatitis C virus (HCV) infection incidence among people who inject drugs and number of new annual HCV infections attributable to injecting drug use: a multi-stage analysis.
Adelina Artenie, Adam Trickey, Katharine J Looker, Jack Stone, Aaron G Lim, Peter Vickerman

Lancet Gastroenterol Hepatol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tuberculosis and people who use drugs: why focus on this overlooked population is important and why adapted interventions are necessary.
Morgana D'Ottavi, Peter Godfrey-Faussett, Corinne S Merle, Mircea T Sofonea, Didier Laureillard, Peter Vickerman

Lancet Glob Health· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis